FORMAC Pharmaceuticals NV is a pharmaceutical contract R&D company that uses a bio-availability enhancing silica-based drug delivery technology to formulate poorly soluble drugs. FORMAC offers it's technology to drug R&D companies who look for solutions to formulate their poorly soluble drug candidates into drug products with improved bio-availability. FORMAC's technology allows the development of new drug products using a single formulation from preclinical testing over phase 1, 2 and 3 clinical trial and into the market.

20 January 2012 — FORMAC Pharmaceuticals announces management changes

FORMAC has a wide array of silica drug carriers that can be tuned to a specific release rate and resulting in supersaturation leading to increased bio-availability. The silica's can also lead to the removal of food effect or result in targeted delivery into the small intestine.

With an increasing number of poorly water soluble compounds in development, there is a definite need to provide new solutions to increase biovailability. FORMAC's innovative silica based drug delivery offers solutions to molecules in the current pipeline but also for improving marketed product performances.